Navigation Links
Arcturus Therapeutics Announces Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH)
Date:12/6/2016

SAN DIEGO, Dec. 6, 2016 /PRNewswire/ -- Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), a leading RNA medicines company, announced today that it entered into collaboration with Takeda Pharmaceutical Company Limited, to develop RNA-based therapeutics for the treatment of NASH and other gastrointestinal (GI) related disorders, utilizing Arcturus' wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer chemistry. The financial terms were not disclosed.

"Given Takeda's long-standing commitment to and expertise in GI disorders, we are confident we have found an ideal partner to accelerate and maximize the potential of our LUNAR and UNA technology platforms toward the development of novel RNA therapeutics for the treatment of NASH," said Dr. Pad Chivukula, CSO & COO of Arcturus Therapeutics, Inc. "This agreement underscores Arcturus' ability to rapidly discover, design and optimize RNA medicines in areas of unmet need." 

About Arcturus Therapeutics, Inc.   

Founded in 2013 and based in San Diego, Arcturus Therapeutics, Inc. is an RNA medicines company with enabling technologies — UNA Oligomer chemistry and LUNAR™ nanoparticle delivery. Arcturus' versatile RNA therapeutics platform can be applied toward all types of RNA medicines including small interfering RNA, messenger RNA, antisense RNA, microRNA and gene editing therapeutics. The company owns LUNAR™ nanoparticle delivery and unlocked nucleomonomer agent (UNA) technology including UNA Oligomers™, which are covered by its patent portfolio (77 patents and patent applications, issued in the U.S., Europe, Japan and other countries). Arcturus' proprietary UNA technology can be used to target any gene in the human genome, as well as viral genes, and other species for therapeutic purposes. The Company's commitment to the development of novel RNA therapeutics has led to collaborations and license agreements with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Ultragenyx Pharmaceutical, Inc. For more information, visit www.ArcturusRx.com.

Logo - http://photos.prnewswire.com/prnh/20130531/MM24393LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arcturus-therapeutics-announces-collaboration-with-takeda-pharmaceuticals-to-develop-rna-based-therapeutics-for-the-treatment-of-nonalcoholic-steatohepatitis-nash-300373830.html


'/>"/>
SOURCE Arcturus Therapeutics
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Arcturus Therapeutics Receives Intent to Grant Notice from the European Patent Office for their Unlocked Nucleomonomer Agent (UNA) Technology
2. Arcturus Therapeutics Announces the Appointment of Drew Weissman M.D., Ph.D. to the Scientific Advisory Board
3. Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications
4. Arcturus Therapeutics to Present at the Genetic Rx Boston Biotech Conference
5. Arcturus Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
6. Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program
7. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
8. Viking Therapeutics Receives Orphan Drug Designation for VK0214 from the U.S. Food and Drug Administration for the Treatment of X-Linked Adrenoleukodystrophy
9. Mission Therapeutics Appoints Colin Goddard as Chairman
10. Research Reports Initiation on Healthcare Stocks -- NuVasive, Smith & Nephew, Nxstage Medical, and Cesca Therapeutics
11. Research Reports Coverage on Biotech Stocks -- Celldex Therapeutics, Amicus Therapeutics, Navidea Biopharma, and Concordia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2018)... (PRWEB) , ... October 13, 2018 , ... As news ... 14.4 per cent over the next five years, from $3200 million in 2017 to ... driver and could even help drive this growth further. This news comes hot on ...
(Date:10/11/2018)... ... October 11, 2018 , ... doeLEGAL, a ... law departments and law firms, today announced it is sponsoring the 2018 ACC ... to learn how corporate legal departments are using smart data, intelligently delivered to ...
(Date:10/11/2018)... ... ... Alice* is artistic, intelligent and on her third school placement. Her parents remember that she ... bed covers, often waking up in a pool of sweat with terrifying nightmares that no ... everything, howled when she was separated from her parents and often demanded to sleep in ...
Breaking Medicine Technology:
(Date:10/16/2018)... ... October 16, 2018 , ... CCC ( Compressor Controls Corporation ... operators today announces Total Train Comprehensive Release version 14.1 (TTCR 14.1), available for ... focused on improving cybersecurity defense around turbomachinery. The upgrade process is seamless, ...
(Date:10/16/2018)... ... , ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has announced ... the first G7 country in the world to formally legalize the recreational production and ... the production and use of cannabis edibles. , More than one in four Canadians ...
(Date:10/16/2018)... ... 2018 , ... AutismOne, the nation’s largest and most-comprehensive annual ... Annual International HPV Vaccine Education Symposium. , Presenters from countries around the globe ... May 24, 2019, with a keynote address from Robert F. Kennedy, Jr., Esq., ...
(Date:10/13/2018)... ... , ... This World Food Day – Tuesday, October 16 – Rise ... by 2030 by breaking a GUINNESS WORLD RECORDS title with volunteers around the globe. ... and five international locations together to break the GUINNESS WORLD RECORDS title for the ...
(Date:10/11/2018)... ... October 11, 2018 , ... Four weeks before ... manipulation,” warns former U.S. Department of Homeland Security deputy assistant secretary Paul Rosenzweig ... We Can Stop it. , Pointing to the ability of Russian hackers to ...
Breaking Medicine News(10 mins):